Premium Information is available for this item - Upgrade for $1 a day
6505-01-316-5679
Usp Cyproheptadine Hydrochloride Tablets
6505013165679 013165679 NDC00182-1132-10 12083
INC: 34173 Cyproheptadine Hydrochloride Tablets
January 2023
5
Marketplace 6505-01-316-5679
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-316-5679 5+ Documents (More...)
RQST NE Updated Every Day 6505-01-316-5679 RQST Updated Every Day 6505-01-316-5679 RQST NE Related
Documents 6505-01-316-5679 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505
6505-00-890-1884 6505-01 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-316-5679 Usp Cyproheptadine
Hydrochloride Tablets Hydrochloride Tablets 6505-01-316-5679 Usp Cyproheptadine Hydrochloride Tablets
6505-00-890-1884 6505-01-240-8699 6505-21-870-8357 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-316-5679
Usp Cyproheptadine Hydrochloride Tablets 6505-00-890-1884 6505-01-240-8699 6505-21-870-8357 6505-01-316-5679
www.nsnlookup.com /fsg-65/fsc-6505/ca 6505-21-848-2049 Cyproheptadine Hydrochloride Tablets -8357 6505-01-316-5679
fsc-6505/ca 6505-21-848-2049 Usp Cyproheptadine Hydrochloride Tablets 6505-21-848-2049 -8357 6505-01-316-5679
Usp Cyproheptadine Hydrochloride Tablets Cyproheptadine Hydrochloride Tablets 6505-01-316-5679
Usp Cyproheptadine Hydrochloride Tablets -8357 6505-01-316-5679 6505-00-890-1884 21-848-2049 Usp
Restrictions 6505-01-316-5679
6505-01-316-5679 is a Usp Cyproheptadine Hydrochloride Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-316-5679
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-316-5679
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-316-5679
- Part Number
- Manufacturer
- Status
- NDC00182-1132-10
- Manufacturer
- 2U436 - Goldline Laboratories (Active)
- Primary Buy
- Primary Buy
- 12083
- 2U436 - Goldline Laboratories (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-01-316-5679
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 4.000 Milligrams Cyproheptadine Hydrochloride Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 1000.000 Tablets
Management Data 6505-01-316-5679
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Mar 1990
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 1000 Tt
- 00000001000TT
- K
Similar Supply Items to 6505-01-316-5679
Freight Information 6505-01-316-5679
6505-01-316-5679 has freight characteristics.. 6505-01-316-5679 has a variance between NMFC and UFC when transported by rail and the description should be consulted.